Literature DB >> 3987000

Fluorometric assay for phospholipase A2 in serum.

T Thuren, J A Virtanen, M Lalla, P K Kinnunen.   

Abstract

In this fluorometric assay for phospholipase A2 (EC 3.1.1.4) in serum we use the fluorescent phospholipid analog 1-octacosanyl-2-(pyren-1-yl)hexanoyl-sn-glycero-3-phosphatid yl monomethyl ester as substrate. The optimized conditions are: 28 mumol of the substrate per liter of Tris buffer (20 mmol/L, pH 7.4). The hydrolytic reaction is allowed to proceed for 30 min at 37 degrees C. The fluorescent reaction product, (pyren-1-yl)hexanoic acid, is then separated from the unreacted substrate by liquid-liquid phase partition. The concentration of the liberated fatty acid analog is determined fluorometrically. The detection limit is approximately 6 pmol min-1 mL-1. Forty duplicate samples can be assayed in about 2 h. The activity of this enzyme in serum of 20 healthy volunteers averaged 69 pmol min-1 mL-1. For seven patients with clinically diagnosed pancreatitis the average activity was 1092 pmol min-1 mL-1.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987000

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  10 in total

1.  Characteristics of the binding of tacrine to acidic phospholipids.

Authors:  J Y Lehtonen; M Rytömaa; P K Kinnunen
Journal:  Biophys J       Date:  1996-05       Impact factor: 4.033

2.  Modified photometric method for the determination of phospholipase A activities.

Authors:  G E Hoffmann; U Neumann
Journal:  Klin Wochenschr       Date:  1989-02-01

3.  Helicobacter pylori associated phospholipase A2 activity: a factor in peptic ulcer production?

Authors:  S R Langton; S D Cesareo
Journal:  J Clin Pathol       Date:  1992-03       Impact factor: 3.411

4.  The diagnostic value of serum pancreatic phospholipase A2 (PLA2) in pancreatic diseases.

Authors:  M Kitagawa; T Hayakawa; T Kondo; T Shibata; Y Sakai; H Sobajima; H Ishiguro; Y Nakae
Journal:  Gastroenterol Jpn       Date:  1991-02

5.  Effect of a selective thromboxane A2 synthetase inhibitor on the systemic changes induced by circulating pancreatic phospholipase A2.

Authors:  Makoto Motoyoshi; Masanori Sugiyama; Yutaka Atomi; Wataru Kimura; Hirokazu Nagawa
Journal:  J Gastroenterol       Date:  2006-12-08       Impact factor: 7.527

6.  Polyamine-phospholipid interaction probed by the accessibility of the phospholipid sn-2 ester bond to the action of phospholipase A2.

Authors:  T Thuren; J A Virtanen; P K Kinnunen
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

7.  Urinary phospholipase A2 excretion in chronic pancreatic diseases.

Authors:  C Fabris; D Basso; M P Panozzo; G Del Favero; T Meggiato; M Plebani; C Ferrara; P Fogar; M Zaninotto; R Naccarato
Journal:  Int J Pancreatol       Date:  1992-06

8.  Immobilization of Lipid Substrates: Application on Phospholipase A2 Determination.

Authors:  Athanassios Karkabounas; Dimitra G Georgiadou; Panagiotis Argitis; Vassilios Psycharis; George Nakos; Agni M Kosmas; Marilena E Lekka
Journal:  Lipids       Date:  2015-10-08       Impact factor: 1.880

Review 9.  Serum phospholipase--regulatory and pathophysiological aspects.

Authors:  G E Hoffmann; W G Guder
Journal:  Klin Wochenschr       Date:  1989-02-01

10.  Assay of phospholipases A(2) and their inhibitors by kinetic analysis in the scooting mode.

Authors:  M K Jain; B Z Yu; M H Gelb; O G Berg
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.